NPI: 1730179714 · BRADENTON, FL 34202 · General Acute Care Hospital · NPI assigned 10/21/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 10/21/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,347 | $106K |
| 2019 | 25,297 | $444K |
| 2020 | 23,044 | $425K |
| 2021 | 28,366 | $713K |
| 2022 | 31,256 | $1.27M |
| 2023 | 13,589 | $711K |
| 2024 | 3,542 | $233K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,073 | 10,177 | $971K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,355 | 8,952 | $868K |
| 36415 | Collection of venous blood by venipuncture | 10,484 | 8,224 | $479K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,029 | 5,145 | $355K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,554 | 2,378 | $245K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 691 | 599 | $180K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 788 | 700 | $167K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,110 | 899 | $145K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,999 | 2,576 | $143K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,748 | 1,604 | $26K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 979 | 865 | $24K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 931 | 787 | $24K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,558 | 2,463 | $23K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 353 | 195 | $23K |
| 87070 | 904 | 766 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | 1,626 | 1,429 | $20K |
| 80053 | Comprehensive metabolic panel | 6,780 | 5,653 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,675 | 1,459 | $12K |
| 81003 | 1,517 | 1,314 | $12K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 274 | 243 | $12K |
| G0378 | Hospital observation service, per hour | 622 | 510 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,762 | 3,881 | $11K |
| 81001 | 5,052 | 4,364 | $10K | |
| 71045 | Radiologic examination, chest; single view | 2,379 | 2,002 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,587 | 927 | $8K |
| 81025 | 3,587 | 3,164 | $8K | |
| 87077 | 789 | 516 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,211 | 1,821 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,652 | 7,200 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 695 | 631 | $6K |
| 87420 | 161 | 151 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 26 | 25 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,962 | 2,410 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 224 | 201 | $5K |
| 73610 | 85 | 80 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 194 | 163 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 130 | 119 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,832 | 2,361 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 339 | 293 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,679 | 2,262 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,265 | 897 | $1K |
| 73564 | 57 | 52 | $1K | |
| 85610 | 1,491 | 1,234 | $1K | |
| 73630 | 164 | 144 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 51 | 37 | $1K |
| 85730 | 1,113 | 923 | $1K | |
| A9270 | Non-covered item or service | 1,358 | 445 | $1K |
| 73110 | 48 | 40 | $940.09 | |
| 87430 | 731 | 681 | $872.27 | |
| 84484 | 1,979 | 1,267 | $832.76 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 291 | 251 | $704.33 |
| 83690 | 3,078 | 2,606 | $683.93 | |
| 83735 | 1,199 | 976 | $676.66 | |
| 87186 | 797 | 541 | $504.85 | |
| 76801 | 82 | 76 | $404.57 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 578 | 452 | $367.73 |
| 84702 | 803 | 681 | $361.90 | |
| 86900 | 387 | 342 | $326.30 | |
| 73130 | 59 | 55 | $323.76 | |
| 85027 | 339 | 286 | $276.90 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 458 | 425 | $265.58 |
| 82948 | 48 | 28 | $231.84 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 338 | 294 | $209.04 |
| 86901 | 387 | 342 | $207.81 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 357 | 300 | $181.36 |
| J2704 | Injection, propofol, 10 mg | 348 | 286 | $171.51 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,148 | 1,012 | $164.33 |
| 87040 | 126 | 65 | $159.46 | |
| 74018 | 13 | 13 | $145.84 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 948 | 828 | $113.90 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 751 | 651 | $105.85 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 40 | 39 | $69.59 |
| 96376 | 37 | 25 | $40.69 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,724 | 2,333 | $26.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 500 | 412 | $25.87 |
| 80076 | 139 | 117 | $23.14 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 127 | 114 | $18.36 |
| 83880 | 123 | 105 | $16.98 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 117 | 97 | $0.00 |
| 86850 | 16 | 14 | $0.00 | |
| 83605 | 15 | 12 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 29 | 26 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 46 | 38 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 44 | 38 | $0.00 |
| 82962 | 21 | 13 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 13 | 12 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 222 | 186 | $0.00 |
| 0353U | 13 | 12 | $0.00 | |
| 82140 | 15 | 13 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 12 | 12 | $0.00 |